Sergi Trilla, Chief Executive Officer at Trifermed (Barcelona). Professor on the Master’s of Innovation and Entrepreneurship in Healthcare at ESADE.
Director, Business Development and Industry Engagement, University of Buffalo (New York Area)
Alan Belicha, Director, Business Development and Industry Engagement at University of Buffalo.
Stephen Dunne, Managing Director at Neuroelectrics. Experience translating cutting-edge R&D into real-world technologies.
Director of Global Outreach Programs, Stanford Byers Center for Biodesign (California)
Anurag Mairal, Director, Global Outreach Programs Stanford Byers Center for Biodesign. Medtech Innovator, Professor, Entrepreneur in healthcare.
John M. Collins, Chief Operating Officer at Massachusetts Institute of Technology (CIMIT, Boston). Leader in technology-driven businesses with more than 25 years of hands-on, international experience in managing P&L centers and creating value by identifying business opportunities and accelerating the development and commercialization of innovative products and services.
Andrés Montefeltro, Senior Vice President, Research Head and Founder at nLife Therapeutics in Granada. His specialties are Fund Rising, Strategic Development, Technology guidance, Innovation process, Knowledge Management.
Associate Professor of Otolaryngology and Chief of Sleep Surgery, Stanford University (California)
Robson Capasso, Associate Professor of Otolaryngology, Chief of Sleep Surgery. Lead on Otoinnovation (Stanford University). Biodesign Mentor and Advisor
Carlos Gallardo, Founder and Managing Director at CG Health Ventures. Seed capital and support to start ups looking to bring innovative solutions to health care.
Ari Silverman, Healthcare Investor and Business Builder at MAVIE Technologies (Barcelona). Extensive experience in company/product growth strategies, commercial operations transformations, digital strategies, government collaboration, and talent and leadership development.
Josep Maria Martorell, Associate Director of the Barcelona Supercomputing Center, an associate professor at the UPC Image Processing and Multimedia Technology Center and an advisor to several technology companies.
Inma Valle, Co-founder & Chief Executive Officer, Metabostem (Barcelona). Independent Advisor for early stage Biotechnology companies and seed investor, focused on Health care.
Jose Antonio. Investment Director, Caixa Capital Risc (Barcelona). Venture capital, investing in early stage biotech and medical device companies.
Clara Campàs-Moya holds a PhD in Pharmacy by the Universitat de Barcelona. She recently joined Kern Pharma SL as Strategy & Development Director were she coordinates the following departments: R&D, innovation, business development and regulatory affairs. Formerly, she worked at Advancell, SA as Managing Director and Drug development Director, as well as a Researcher at Hospital del Mar. She is the co-author of the patent Acadesine, the first drug originated in a Spanish public University that successfully reached clinical trials. She is member of the scientific committee of the venture capital fund HealthEquity, VicePresident of CataloniaBIO and member of the board of trustees of Biocat, as well as member of the scientific committee of the MIHealth Forum.
Javier Megias, CEO & Co-Founder, Startupxplore (Valencia). Entrepreneur and investor passionate about innovation and entrepreneurship
Marcel Prunera, Co-Founder and Managing Partner, Future Companies (Barcelona). Expert in Corporate finance, M&A.
Partha Ray, Director of Surgical Innovation, Johnson & Johnson (San Francisco) and Stanford Biodesign Fellow 2009-2010. Healthcare marketing and innovation executive with blend of corporate, venture capital and startup experience.
Montserrat Vendrell, CEO, Alta Life Sciences (Barcelona). Venture Capital firm in Life Sciences. She has over 10 year experience in biomedical research both in Spanish institutions (CSIC) and international companies (Roche Institute of Molecular Biology)